Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use

Global cancer statistics

Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679

Global Cancer Statistics, 2002

Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196

A genetic model for colorectal tumorigenesis

Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277

5-Fluorouracil: mechanisms of action and clinical strategies

Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215

Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative

Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215

Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆

VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519

Hereditary Colorectal Cancer

Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,147

Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence

WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143

Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis

Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830

Phases of Biomarker Development for Early Detection of Cancer

Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592

American Cancer Society Guidelines for the Early Detection of Cancer

Smith, R. A., Cokkinides, V., von Eschenbach, A. C., Levin, B., Cohen, C., Runowicz, C. D., Sener, S., Saslow, D., & Eyre, H. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.8 · Cited by 1,588

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337

Cancer risk in mutation carriers of DNA-mismatch-repair genes

Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137

Systemic Therapy for Colorectal Cancer

Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer

Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888

Systemic Therapy for Colorectal Cancer

Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

Andreyev, H. J. N., Norman, A. R., Cunningham, D., Oates, J., Dix, B. R., Iacopetta, B. J., Young, J., Walsh, T., Ward, R., Hawkins, N., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1964 · Cited by 872

Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH

Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 862

Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative

Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Clinical Chemistry · doi:10.1373/49.1.1 · Cited by 862

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

Simmonds, P. C., Primrose, J. N., Colquitt, J. L., Garden, O. J., Poston, G. J., & Rees, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603033 · Cited by 858

Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors

Lindor, N. M., Burgart, L. J., Leontovich, O. N., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., Walsh-Vockley, C., Petersen, G. M., Walsh, M. D., Leggett, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1043 · Cited by 817

Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population

Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Turnbull, B. A., & Ross, M. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033403 · Cited by 803

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794

Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?

Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794

Familial adenomatous polyposis

Galiatsatos, P., & Foulkes, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00375.x · Cited by 757

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.189 · Cited by 751

Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748

Kirsten ras mutations in patients with colorectal cancer: The multicenter “RASCAL” study

Andreyev, H. J. N., Norman, A. R., Clarke, P. A., Cunningham, D., & Oates, J. R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.675 · Cited by 748

Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force

Pignone, M., Rich, M., Teutsch, S. M., Berg, A. O., & Lohr, K. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00015 · Cited by 741

Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors

Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1566048 · Cited by 698

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials

Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002) · BMJ · doi:10.1136/bmj.324.7341.813 · Cited by 651

Biallelic inactivation of hMLH 1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers

Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648

Follow-up strategies for patients treated for non-metastatic colorectal cancer

Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640

American Cancer Society Guidelines for the Early Detection of Cancer, 2006

Smith, R. A., Cokkinides, V., & Eyre, H. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.1.11 · Cited by 639

Recommendations for the Care of Individuals With an Inherited Predisposition to Lynch Syndrome: A Systematic Review

Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., & Press, N. (2006) · JAMA · doi:10.1001/jama.296.12.1507 · Cited by 629

Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel

Ahlquist, D. A., Skoletsky, J. E., Boynton, K. A., Harrington, J. J., Mahoney, D. W., Pierceall, W. E., Thibodeau, S. N., & Shuber, A. P. (2000) · Gastroenterology · doi:10.1053/gast.2000.19580 · Cited by 533

Accuracy of Revised Bethesda Guidelines, Microsatellite Instability, and Immunohistochemistry for the Identification of Patients With Hereditary Nonpolyposis Colorectal Cancer

Piñol, V. (2005) · JAMA · doi:10.1001/jama.293.16.1986 · Cited by 525

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

Carethers, J. M., Smith, E. J., Behling, C. A., Nguyen, L., Tajima, A., Doctolero, R. T., Cabrera, B. L., Goel, A., Arnold, C. A., Miyai, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.023 · Cited by 471

Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.

Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Möslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., et al. (1996) · PubMed · Cited by 466

Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Systematic Review and Meta-Analysis

Popat, S., Matakidou, A., & Houlston, R. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.064 · Cited by 449

Mismatch repair proficiency and in vitro response to 5-fluorouracil

Carethers, J. M., Chauhan, D. P., Fink, D., Nebel, S., Bresalier, R. S., Howell, S. B., & Boland, C. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70558-5 · Cited by 429

The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant Treatment

Russo, A., Bazan, V., Iacopetta, B., Kerr, D., Soussi, T., & Gebbia, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.471 · Cited by 416

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

Figueredo, A., Rumble, R. B., Maroun, J., Earle, C. C., Cummings, B., McLeod, R., Zuraw, L., Zwaal, C., & the members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care (2003) · BMC Cancer · doi:10.1186/1471-2407-3-26 · Cited by 392

Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis

(2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.104 · Cited by 389

Clinical utility of biochemical markers in colorectal cancer

Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Klapdor, R., Lamerz, R., Nilsson, O., Sturgeon, C., & Topolcan, O. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00811-0 · Cited by 374

Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

Chen, W.-D., Han, Z. J., Skoletsky, J., Olson, J., Sah, J., Myeroff, L., Platzer, P., Lu, S., Dawson, D., Willis, J., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji204 · Cited by 370

AGA technical review on hereditary colorectal cancer and genetic testing

(2001) · Gastroenterology · doi:10.1053/gast.2001.25581 · Cited by 347

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

Domingo, E., Laiho, P., Ollikainen, M., Pinto, M., Wang, L., French, A. J., Westra, J., Frebourg, T., Espín, E., Armengol, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020651 · Cited by 339

Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets

Dong, S. M., Traverso, G., Johnson, C., Geng, L., Favis, R., Boynton, K., Hibi, K., Goodman, S. N., D'Allessio, M., Paty, P., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.858 · Cited by 337

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

Bruinvels, D. J., Stiggelbout, A. M., Kievit, J., van Houwellngen, H. C., F. Habbema, J. D., & van de Velde, C. J. H. (1994) · Annals of Surgery · doi:10.1097/00000658-199402000-00009 · Cited by 322

Decrease in Mortality in Lynch Syndrome Families Because of Surveillance

de Jong, A. E., Hendriks, Y. M. C., Kleibeuker, J. H., de Boer, S. Y., Cats, A., Griffioen, G., Nagengast, F. M., Nelis, F. G., Rookus, M. A., & Vasen, H. F. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.032 · Cited by 302

P53 abnormalities and outcomes in colorectal cancer: a systematic review

Munro, A. J., Lain, S., & Lane, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602358 · Cited by 289

Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines

Arnold, C. N., Goel, A., & Boland, C. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11176 · Cited by 280

Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

Buckowitz, A., Knaebel, H.-P., Benner, A., Bläker, H., Gebert, J., Kienle, P., von Knebel Doeberitz, M., & Kloor, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602534 · Cited by 264

Risk of hepatoblastoma in familial adenomatous polyposis

Giardiello, F. M., Offerhaus, G. J. A., Krush, A. J., Booker, S. V., Tersmette, A. C., Mulder, J.-W. R., Kelley, C. N., & Hamilton, S. R. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80297-5 · Cited by 255

ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

Guillem, J. G., Wood, W. C., Moley, J. F., Berchuck, A., Karlan, B. Y., Mutch, D. G., Gagel, R. F., Weitzel, J., Morrow, M., Weber, B. L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5260 · Cited by 245

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R., & Bertino, J. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00079-0 · Cited by 242

P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

Elsaleh, H., Powell, B. L., McCaul, K. A., Grieu, F., Grant, R., Joseph, D., & Iacopetta, B. J. (2001) · PubMed · Cited by 204

Follow-up of colorectal cancer: A meta-analysis

Rosen, M., Chan, L., Beart, R. W., Vukasin, P., & Anthone, G. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02239433 · Cited by 192

Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis

Fearnhead, N. S., Wilding, J. L., & Bodmer, W. F. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.27 · Cited by 179

Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians

Hendriks, Y. M. C., de Jong, A. E., Morreau, H., Tops, C. M. J., Vasen, H. F., Wijnen, J. T., Breuning, M. H., & Brocker-Vriends, A. H. J. T. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.4.213 · Cited by 178

Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.

Giardiello, F. M., Petersen, G. M., Brensinger, J. D., Luce, M. C., Cayouette, M. C., Bacon, J., Booker, S. V., & Hamilton, S. R. (1996) · Gut · doi:10.1136/gut.39.6.867 · Cited by 169

Molecular pathogenesis of colorectal cancer: Implications for molecular diagnosis

Arnold, C. N., Goel, A., Blum, H. E., & Richard Boland, C. (2005) · Cancer · doi:10.1002/cncr.21462 · Cited by 162

Microsatellite Instability

de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038099 · Cited by 160

Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing

Terdiman, J. P., Gum, J. R., Conrad, P. G., Miller, G. A., WEINBERG, V. K., Crawley, S., Levin, T. R., Reeves, C., Schmitt, A., Hepburn, M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20874 · Cited by 155

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

van Triest, B., Pinedo, H. M., van Hensbergen, Y., Smid, K., Telleman, F., Schoenmakers, P. S., van der Wilt, C. L., van Laar, J. A. M., Noordhuis, P., Jansen, G., et al. (1999) · PubMed · Cited by 145

Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?

Aretz, S., Koch, A., Uhlhaas, S., Friedl, W., Propping, P., von Schweinitz, D., & Pietsch, T. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20698 · Cited by 140

American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing

(2001) · Gastroenterology · doi:10.1053/gast.2001.25580 · Cited by 137

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

Machover, D. (1997) · Cancer · Cited by 135

The adenomatous polyposis coli (APC) tumour suppressor – genetics, function and disease

Sieber, O. M., Tomlinson, I. P. M., & Lamlum, H. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01828-1 · Cited by 123

MutYH (MYH) and colorectal cancer

Sampson, J. R., Jones, S., Dolwani, S., & Cheadle, J. P. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330679 · Cited by 121

Screening for colorectal cancer: recommendations and rationale.

Berg, A. O. (2002) · PubMed · Cited by 116

Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer

Engel, C., Forberg, J., Holinski‐Feder, E., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21313 · Cited by 102

Phenotypic Expression of Disease in Families That Have Mutations in the 5′ Region of the Adenomatous Polyposis Coli Gene

Giardiello, F. M., Brensinger, J. D., Luce, M. C., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-7-199704010-00003 · Cited by 102

Mutant KRAS, chromosomal instability and prognosis in colorectal cancer

Castagnola, P., & Giaretti, W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.003 · Cited by 91

Inherited Susceptibility to Colorectal Cancer

Rowley, P. T. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.061704.135235 · Cited by 88

p53: link to the past, bridge to the futurePreprint

Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 81

Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer

de Leòn, M. P., Benatti, P., Gregorio, C. D., Pedroni, M., Losi, L., Genuardi, M., Viel, A., Fornasarig, M., Cordisco, E. L., Anti, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601529 · Cited by 68

Role of Genomic Markers in Colorectal Cancer Treatment

Allen, W. L., & Johnston, P. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.752 · Cited by 66

Current treatment for colorectal cancer metastatic to the liver

Cromheecke, M., de Jong, K. P., & Hoekstra, H. J. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0679 · Cited by 65

Prognostic and predictive molecular markers in colorectal carcinoma.

Bendardaf, R., Lamlum, H., & Pyrhönen, S. O. (2004) · PubMed · Cited by 59

Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?

Bertino, J. R., & Banerjee, D. (2003) · PubMed · Cited by 41

The Promise of Biomarkers in Colorectal Cancer Detection

Umar, A., & Srivastava, S. (2004) · Disease Markers · doi:10.1155/2004/303016 · Cited by 14

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041

Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)

Chan, E. C. Y., Koh, P. K., Mal, M., Cheah, P. Y., Eu, K. W., Backshall, A., Cavill, R., Nicholson, J. K., & Keun, H. C. (2009) · Journal of Proteome Research · doi:10.1021/pr8006232 · Cited by 444

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

Duffy, M. J., Lamerz, R., Haglund, C., Nicolini, A., Kalousová, M., Holubec, L., & Sturgeon, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.28384 · Cited by 360

Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers

Duffy, M. J. (2013) · Medical Principles and Practice · doi:10.1159/000338393 · Cited by 278

Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer

Akins, N. S., Nielson, T. C., & Le, H. V. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180523111351 · Cited by 253